Breaking News Instant updates and real-time market news.

2019-12-02 07:13:20 CFG Citizens Financial $38.03 -0.62 (-1.60%) 07:13 12/02/19 12/02 07:13 12/02/19 07:13	Citizens FinancialCitizens Financial management to meet with Wedbush Meeting to be held in Providence, RI on December 3 hosted by Wedbush.	03 Dec 17 Jan 26 Feb
CFG Citizens Financial $38.03 -0.62 (-1.60%) 07/29/19 ARGS 07/29/19 UPGRADE ARGS Buy Citizens Financial upgraded to Buy from Hold at Argus 07/29/19 ARGS 07/29/19 UPGRADE Target $43 ARGS Buy Citizens Financial upgraded to Buy from Hold at Argus Argus analyst Kevin Heal upgraded Citizens Financial to Buy with a price target of $43 citing its "strong revenue growth" over the recent quarters, along with "record gains" in capital markets, mortgage banking, and credit card services. The analyst further cites the management's focus on capital returns, having recently boosted its dividend by 13% and disclosed a $121M stock buyback during Q2. Heal contends that Citizens Financial should be valued at a premium relative to peers, but the stock trades at 9.7-times his expected FY19 earnings vs. the average regional bank peer multiple of 11.0-times. 09/06/19 BOFA 09/06/19 NO CHANGE BOFA BofA/Merrill sees Citi, Citizens BB&T risk/reward as 'compelling' BofA Merrill Lynch analyst Erika Najarian said she does not believe bank stocks are pricing in a recession, though they are "bearing the brunt of cycle concerns." Bank stocks could be at a near-term bottom, said Najarian, who sees compelling risk/rewards for shares of Citi (C), Citizens Financial (CFG) and BB&T (BBT) even when taking into account theoretical fair value in a recession. Even in the case of a recession, banks have materially improved underwriting since the financial crisis and she estimates an average 46% EPS hit in a downturn but only a 5% hit in tangible book value versus consensus 2020 forecasts, Najarian tells investors. 10/08/19 SBSH 10/08/19 DOWNGRADE SBSH Sell Citizens Financial downgraded to Sell from Neutral at Citi Citi analyst Keith Horowitz downgraded Citizens Financial Group to Sell from Neutral.

2019-12-02 07:13:20

CFG

Citizens Financial

$38.03: -0.62 (-1.60%)

07:13

12/02/19

12/02

07:13

12/02/19

07:13

Citizens FinancialCitizens Financial management to meet with Wedbush

Meeting to be held in Providence, RI on December 3 hosted by Wedbush.

03
Dec
17
Jan
26
Feb

CFG Citizens Financial

$38.03: -0.62 (-1.60%)

07/29/19: ARGS

07/29/19: ARGS

09/06/19: BOFA

10/08/19: SBSH

TODAY'S FREE FLY STORIES

CRBP Corbus Pharmaceuticals $5.08 0.16 (3.25%) 08:43 12/13/19 12/13 08:43 12/13/19 08:43 Conference/Events	Corbus Pharmaceuticals to hold a webinar » Expert panel discusses… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec
EV Eaton Vance $47.08 0.395 (0.85%) 08:42 12/13/19 12/13 08:42 12/13/19 08:42 Upgrade	Eaton Vance rating change » Eaton Vance upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TTMI TTM Technologies $13.79 0.19 (1.40%) 08:41 12/13/19 12/13 08:41 12/13/19 08:41 Upgrade	TTM Technologies rating change » JPMorgan upgrades TTM… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AJG Arthur J. Gallagher $94.63 0.16 (0.17%) 08:39 12/13/19 12/13 08:39 12/13/19 08:39 Conference/Events	Arthur J. Gallagher to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Dec
NEWR New Relic $66.87 0.86 (1.30%) 08:38 12/13/19 12/13 08:38 12/13/19 08:38 Recommendations	New Relic analyst commentary » Morgan Stanley came way… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

AMK AssetMark Financial $27.31 0.42 (1.56%) 08:38 12/13/19 12/13 08:38 12/13/19 08:38 Upgrade	AssetMark Financial rating change » JPMorgan upgrades… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
LII Lennox $259.14 0.71 (0.27%) 08:38 12/13/19 12/13 08:38 12/13/19 08:38 Conference/Events	Lennox to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Dec
VIAC ViacomCBS $37.79 0.52 (1.40%) 08:36 12/13/19 12/13 08:36 12/13/19 08:36 Initiation	ViacomCBS initiated » ViacomCBS reinstated with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CLRB Cellectar Biosciences $2.23 0.12 (5.69%) 08:35 12/13/19 12/13 08:35 12/13/19 08:35 Hot Stocks	Cellectar Biosciences presents data on CLR 2000045 at AACR symposium » Cellectar Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
OCFT OneConnect $0.00 (0.00%) 08:35 12/13/19 12/13 08:35 12/13/19 08:35 Syndicate	OneConnect 31.2M share IPO priced at $10.00 » The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec

ONCS OncoSec $2.39 -0.04 (-1.65%) , MRK Merck $88.95 0.6 (0.68%) 08:34 12/13/19 12/13 08:34 12/13/19 08:34 Hot Stocks	OncoSec reports interim results from KEYNOTE-890 study » OncoSec announced interim… ONCS OncoSec $2.39 -0.04 (-1.65%) MRK Merck $88.95 0.6 (0.68%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	17 Dec 24 Jan 24 Jan 05 Feb 14 Mar
CFX Colfax $35.74 0.6 (1.71%) 08:34 12/13/19 12/13 08:34 12/13/19 08:34 Conference/Events	Colfax to host investor day » Investor day to be held… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Dec
SRPT Sarepta $100.39 -1.15 (-1.13%) 08:33 12/13/19 12/13 08:33 12/13/19 08:33 Hot Stocks	Sarepta announces $250M of non-dilutive senior secured loan financing » Sarepta Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ADBE Adobe $305.76 2.01 (0.66%) 08:33 12/13/19 12/13 08:33 12/13/19 08:33 Recommendations	Adobe analyst commentary » Adobe price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Jan
ATNX Athenex $16.94 -0.36 (-2.08%) 08:32 12/13/19 12/13 08:32 12/13/19 08:32 Hot Stocks	Athenex announces results from Phase III trial of oral paclitaxel » Athenex announced results… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec

PFE Pfizer $38.54 0.3 (0.78%) 08:32 12/13/19 12/13 08:32 12/13/19 08:32 Hot Stocks	Pfizer announces CHMP recommendation for approval of Vyndaqel » Pfizer announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TREE LendingTree $293.67 -13 (-4.24%) 08:31 12/13/19 12/13 08:31 12/13/19 08:31 Recommendations	LendingTree analyst commentary » LendingTree price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
UNM Unum Group $31.01 0.82 (2.72%) 08:30 12/13/19 12/13 08:30 12/13/19 08:30 Conference/Events	Unum Group to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	17 Dec
08:30 12/13/19 12/13 08:30 12/13/19 08:30 Options	One option delisting on December 13th » Option delistings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
08:25 12/13/19 12/13 08:25 12/13/19 08:25 Conference/Events	Federal Reserve Bank of New York president participates in a discussion » New York Federal Reserve… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial

FORM FormFactor $24.96 1.19 (5.01%) , INTC Intel $57.56 0.52 (0.91%) … 08:25 12/13/19 12/13 08:25 12/13/19 08:25 Recommendations	FormFactor, Intel, Samsung, TSMC analyst commentary » FormFactor price target… FORM FormFactor $24.96 1.19 (5.01%) INTC Intel $57.56 0.52 (0.91%) SSNLF Samsung $0.00 (0.00%) TSM TSMC $58.61 2.71 (4.85%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Dec 23 Jan
$DJT DJ Transportation Average $0.00 (0.00%) 08:24 12/13/19 12/13 08:24 12/13/19 08:24 Technical Analysis	DJ Transportation Average: Pivot points » The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
$DJU DJ Utility Average $0.00 (0.00%) 08:24 12/13/19 12/13 08:24 12/13/19 08:24 Technical Analysis	DJ Utility Average: Pivot points » The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
DJX Dow Jones Industrial Average $0.00 (0.00%) 08:24 12/13/19 12/13 08:24 12/13/19 08:24 Technical Analysis	Dow Jones Industrial Average: Pivot points » The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MAS Masco $47.44 1 (2.15%) , FBHS Fortune Brands $65.51 0.31 (0.48%) 08:24 12/13/19 12/13 08:24 12/13/19 08:24 Recommendations	Masco, Fortune Brands analyst commentary » Masco, Fortune Brands… MAS Masco $47.44 1 (2.15%) FBHS Fortune Brands $65.51 0.31 (0.48%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

IDXG
Today at 09:00

Interpace Biosciences Inc Firm Sponsored Meetings

The New York Times Building, 37th Floor, 620 Eighth Avenue, New York, NY
PCTY
Today at 09:30

Paylocity Holding Corporation Firm Sponsored Meetings

1400 American Lane, Schaumburg, IL
Today at 10:00

Business Inventories M/M: October 2019 Government Event
RCL
Today at 10:00

Royal Caribbean - RCL Conference Calls
VLGEA
Today at 10:00

Village Super Market Inc. Firm Sponsored Meetings

733 Mountain Avenue, Springfield, NJ
PVT
Today at 10:00

Pivotal Acquisition Corp. Firm Sponsored Meetings
FCEL
Today at 10:00

FuelCell Energy Inc. Firm Sponsored Meetings

90 Park Avenue, 35th Floor, New York, NY
LRN
Today at 10:00

K12, Inc. Firm Sponsored Meetings

555 Eleventh Street, N.W., Suite 1000, Washington, D.C., DC
Today at 10:00

Oilfield Services & Equipment Industry Meetings
ATVI ...
Today at 10:30

Digital Media Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust Priced at: $13.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust Priced at: $36.50 1.57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg Priced at: $1.25 28M Shares PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum Priced at: $6.50 15.384M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair Priced at: $22.00 9.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number Priced at: $12.50 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan Priced at: $27.00 2.78M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital Priced at: $18.10 11M Shares MNTA X MNTA Momenta Secondary Managers: Goldman Sachs & JPMorgan, Stifel Priced at: $15.50 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKTS X AKTS Akoustis Spot Secondary Managers: Craig-Hallum, Roth Capital, Loop Capital Priced at: $6.25 4.8M Shares ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $16.50 5.152M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FTSV X FTSV Forty Seven Spot Secondary Managers: Morgan Stanley & Credit Suisse Priced at: $35.00 4.86M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	LULU X LULU Lululemon Block Trade Managers: Morgan Stanley Priced at: $220.00 2.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HCCO X HCCO Healthcare Merger Corp. IPO Managers: Cantor Fitzgerald Priced at: $10.00 22M Shares OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc Priced at: $10.00 31.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel Priced at: $17.00 8.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AEMD X AEMD Aethlon Medical Secondary Managers: H.C. Wainwright Priced at: $1.50 3.333M Shares AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital Priced at: $5.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHR X PHR Phreesia Secondary Managers: JPMorgan, Wells Fargo, William Blair, Allen & Co., Piper Jaffray, Baird, Raymond James Priced at: $26.00 6.75M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	ASPU X ASPU Aspen Group Spot Secondary Managers: Canaccord $7.55 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Citizens FinancialCitizens Financial management to meet with Wedbush

TODAY'S FREE FLY STORIES

Get Full Fly Access